Utrecht / Dundee / Geneva / Kiel / Clermont-Ferrand / Groningen / Izmir / Umanlife / Budapest / Alicante / Tel Aviv / Brighton / Salzburg / Zagreb / Bratislavia / Badajoz / Paris / Alexandroupolis / Integragen / Milano / Heidelberg / Roma / Prague / Nashville / Belgrade / Sarajevo / Duarte / Basel / Goettingen / ILLUMINA / Gent / Marseille / Limoges / /
Company
V. Manolopoulos / B. Melichar / AFFYMETRIX / Helena Murray Co / TEVA / M. Simmaco / /
Continent
Europe / /
Country
Germany / Switzerland / Hungary / Netherlands / Croatia / Italy / Serbia / Belgium / Turkey / France / Japan / Bosnia and Herzegovina / Austria / United States / Slovakia / United Kingdom / Israel / Scotland / Spain / Greece / /
General Assembly / Institut Roche / European Union / /
Person
Pierre Marquet / Uwe Diegel / Peter Jacobs / Ron van Schaik / John Lamont / Ivan Tkac / Cyril Grospiron Patrice Denèfle / Jaroslav Hubacek / Bernard Courtieu / Beata Sperlagh / Sabina Semiz / Maria Judit Molnar / Dan Roden / Gabor Kovacs / Joseph Ciccolini / Ana Peiró / Adrian Llerena / Urs A. Meyer / Hanan Osman / Matthew Albert / Patrice Denefle / Michael Hayden / Scott Kahn / Ron van Schaik Paolo Marchetti / Marc Rancier / Gene Polymorphisms / Markus Paulmichl / Michael Oellerich / Michael Neumaier / Ewan Pearson / Nada Božina / Marc Ansari / Maurizio Ferrari / Marie Judit Molnar / Christoph Funk / Ana Peiro / Cyril Grospiron / Agnes F. Semsei / Sophie Visvikis-Siest / Sanja Stankovic / Behrooz Alizadeh / Samer Khaled / Iris Grossman / Frédéric Libert / Céline Pallaud / /
Product
glipizide / /
Technology
genomics / Pharmacogenomic / Drug Metabolism / Pharmacogenetics / impedance-cell based label free technology / /